The management of leiomyoma uteri by GnRH analogues.
作者信息
Giorgino F L, Cetera C
机构信息
Obstetric and Gynecologic Pathology Department, University of Padua, Italy.
出版信息
Clin Exp Obstet Gynecol. 1991;18(2):137-43.
PMID:1833095
Abstract
Therapy with GnRH analogs is the first medical solution to be really effective in treating uterine fibromas, even if with limited and temporary benefits. Out of the 12 patients treated the Authors observed that a 60% reduction of the volume of the uterus can be achieved after 3-6 months therapy, with rapid recuperation of the initial volume after interruption of the treatment. It is therefore preferable to use GnRH analogs as a propedeutic therapy rather than surgery.
摘要
相似文献
1
The management of leiomyoma uteri by GnRH analogues.
Clin Exp Obstet Gynecol. 1991;18(2):137-43.
2
Immunohistochemical localization of epidermal growth factor receptor in leiomyomas from women treated with goserelin depot.戈舍瑞林长效注射剂治疗的女性平滑肌瘤中表皮生长因子受体的免疫组化定位
Horm Metab Res. 1991 Sep;23(9):442-5. doi: 10.1055/s-2007-1003722.
3
[New possibilities for differentiated therapy of leiomyoma of the uterus using the GnRH agonist zoladex].
Geburtshilfe Frauenheilkd. 1989 Feb;49 Suppl 1:96-8. doi: 10.1055/s-2008-1026587.
4
[Preoperative reduction of uterine leiomyoma by the GnRH-analog goserelin (zoladex)].[使用促性腺激素释放激素类似物戈舍瑞林（诺雷德）对子宫平滑肌瘤进行术前缩小]
Geburtshilfe Frauenheilkd. 1990 Feb;50(2):136-9. doi: 10.1055/s-2007-1026451.
5
Luteinizing hormone-releasing hormone analog therapy of uterine fibroid: analysis of results obtained with buserelin administered intranasally and goserelin administered subcutaneously as a monthly depot.促黄体生成激素释放激素类似物治疗子宫肌瘤：对经鼻给予布舍瑞林和每月皮下注射戈舍瑞林作为长效注射剂所获结果的分析。
Eur J Obstet Gynecol Reprod Biol. 1990 Oct;37(1):63-9. doi: 10.1016/0028-2243(90)90096-j.
6
[Intrauterine pregnancy with uterine myoma after downregulation with GnRH analogs].[GnRH类似物降调节后合并子宫肌瘤的宫内妊娠]
Geburtshilfe Frauenheilkd. 1992 Feb;52(2):121-2. doi: 10.1055/s-2007-1022966.
7
Treatment of peri-menopausal women: potential long-term therapy with a depot GnRH agonist combined with hormonal replacement therapy.
Br J Obstet Gynaecol. 1992 Feb;99 Suppl 7:13-7. doi: 10.1111/j.1471-0528.1992.tb13533.x.
8
Differential reduction in the volume of leiomyoma and uterus during buserelin treatment.布舍瑞林治疗期间平滑肌瘤和子宫体积的差异缩小。
Gynecol Endocrinol. 1994 Mar;8(1):39-43. doi: 10.3109/09513599409028456.
9
The response of uterine fibroids to GnRH-agonist treatment can be predicted in most cases after one month.在大多数情况下，子宫肌瘤对促性腺激素释放激素激动剂治疗的反应在一个月后即可预测。
Eur J Obstet Gynecol Reprod Biol. 1992 Jul 3;45(2):125-9. doi: 10.1016/0028-2243(92)90228-q.
10
Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot.戈舍瑞林（诺雷德）治疗期间子宫肌瘤的缩小：一种作为每月皮下长效注射剂给药的促黄体生成素释放激素激动剂。
Fertil Steril. 1987 Jul;48(1):45-51. doi: 10.1016/s0015-0282(16)59288-7.
引用本文的文献
1
Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in benign gynaecological disorders.戈舍瑞林。对其药效学和药代动力学特性以及在良性妇科疾病中的治疗应用的综述。
Drugs. 1996 Feb;51(2):319-46. doi: 10.2165/00003495-199651020-00009.
Zotero 插件